Skip to main content
Log in

Differential Disruption of Blood–Brain Barrier in Severe Traumatic Brain Injury

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

Traumatic brain injury (TBI) is a significant cause of death and disability in young adults, but not much is known about the incidence and characteristics of blood–brain barrier (BBB) dysfunction in this group. In this proof of concept study, we sought to quantify the incidence of BBB dysfunction (defined as a cerebrospinal fluid (CSF)–plasma albumin quotient of ≥0.007) and examine the relationship between plasma and CSF levels of proteins and electrolytes, in patients with severe TBI.

Methods

We recruited 30 patients, all of whom were receiving hypertonic 20 % saline infusion for intracranial hypertension and had external ventricular drains in situ. Simultaneous CSF and blood samples were obtained. Biochemical testing was performed for sodium, osmolality, potassium, glucose, albumin, immunoglobulin-G, and total protein.

Results

Eleven patients (37 %) showed evidence of impairment of passive BBB function, with a CSF–plasma albumin quotient of ≥0.007. There were strong positive correlations seen among CSF–plasma albumin quotient and CSF–plasma immunoglobulin-G quotient and CSF–plasma total protein quotient (r = 0.967, P < 0.001 and r = 0.995, P < 0.001, respectively). We also found a higher maximum intracranial pressure (24 vs. 21 mmHg, P = 0.029) and a trend toward increased mortality (27 vs. 11 %, P = 0.33) in patients with BBB disruption.

Conclusions

In summary, passive BBB dysfunction is common in patients with severe TBI, and may have important implications for effectiveness of osmotherapy and long-term outcomes. Also, our results suggest that the CSF–plasma total protein quotient, a measurement which is readily available, can be used instead of the CSF–plasma albumin quotient for evaluating BBB dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Coronado VG, McGuire LC, Sarmiento K, et al. Trends in traumatic brain injury in the U.S. and the public health response: 1995–2009. J Saf Res. 2012;43(4):299–307.

    Article  Google Scholar 

  2. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy. J Neurotrauma. 2007;24(Suppl 1):S14–20.

    Google Scholar 

  3. Vialet R, Albanese J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 ml/kg 7.5% saline is more effective than 2 ml/kg 20% mannitol. Crit Care Med. 2003;31(6):1683–7.

    Article  CAS  PubMed  Google Scholar 

  4. Ware ML, Nemani VM, Meeker M, Lee C, Morabito DJ, Manley GT. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery. 2005;57(4):727–36.

    Article  PubMed  Google Scholar 

  5. Kerwin AJ, Schinco MA, Tepas JJ 3rd, Renfro WH, Vitarbo EA, Muehlberger M. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study. J Trauma. 2009;67(2):277–82.

    Article  CAS  PubMed  Google Scholar 

  6. Kamel H, Navi BN, Nakagawa K, Hemphill JC 3rd, Ko NU. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med. 2011;39(3):554–9.

    Article  CAS  PubMed  Google Scholar 

  7. Lazaridis C, Neyens R, Bodle J, DeSantis SM. High-osmolarity saline in neurocritical care: systematic review and meta-analysis. Crit Care Med. 2013;41(5):1353–60.

    Article  PubMed  Google Scholar 

  8. Jeffcote T, Ho KM. Associations between cerebrospinal fluid concentrations, serum albumin concentrations and intracranial pressure in neurotrauma and intracranial haemorrhage. Anaesth Intensive Care. 2010;38:274–9.

    CAS  PubMed  Google Scholar 

  9. The SAFE Study Investigators. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007;357:874–84.

    Article  Google Scholar 

  10. Cooper DJ, Myburgh J, Heritier S, et al. Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma. 2013;30(7):512–8.

    Article  PubMed  Google Scholar 

  11. Blyth BJ, Farhavar A, Gee C, et al. Validation of serum markers for blood–brain barrier disruption in traumatic brain injury. J Neurotrauma. 2009;26:1497–507.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Stahel PF, Morganti-Kossmann MC, Perez D, et al. Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood–brain barrier dysfunction in patients with traumatic brain injury. J Neurotrauma. 2001;18(8):773–81.

    Article  CAS  PubMed  Google Scholar 

  13. Pleines UE, Stover JF, Kossmann T, Trentz O, Morganti-Kossmann MC. Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury. J Neurotrauma. 1998;15(6):399–409.

    Article  CAS  PubMed  Google Scholar 

  14. Maier B, Schwerdtfeger K, Mautes A, et al. Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury. Shock. 2001;15(6):421–6.

    Article  CAS  PubMed  Google Scholar 

  15. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O, Kossmann T. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood–brain barrier function. J Neuroimmunol. 1999;101:211–21.

    Article  CAS  PubMed  Google Scholar 

  16. Morganti-Kossmann MC, Hans VH, Lenzlinger PM, et al. TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood–brain barrier function. J Neurotrauma. 1999;16(7):617–28.

    Article  CAS  PubMed  Google Scholar 

  17. National Health and Medical Research Council, Australian research council, Australian Vice-Chancellor’s Committee. National statement on ethical conduct in human research. Canberra: Australian Government; 2007.

    Google Scholar 

  18. Privitera MD, Zakaria T, Khatri R. Nervous system. In: Kaplan LA, Pesce AJ, editors. Clinical chemistry theory, analysis, correlation. 5th ed. St Louis: Elsevier; 2010. p. 907–8, 923.

    Google Scholar 

  19. Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001;184:101–22.

    Article  CAS  PubMed  Google Scholar 

  20. Marshall LF, Eisenberg H, Jane JA, Marshall SB, Klauber MR. A new classification of head injury based on computerized tomography. J Neurosurg. 1991;75(Suppl):S14–20.

    Google Scholar 

  21. Steyerberg EW, Mushkudiani N, Perel P, et al. Predicting outcome after traumatic brain injury: development and internal validation of prognostic scores based on admission characteristics. PLoS Med. 2008;5(8):e165.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Ho KM. Ten caveats of interpreting correlation coefficient in anaesthesia and intensive care research. Anaesth Intensive Care. 2012;40(4):595–7.

    CAS  PubMed  Google Scholar 

  23. Polderman KH, van de Kraats G, Dixon JM, Vandertop WP, Girbes ARJ. Increases in spinal fluid osmolarity induced by mannitol. Crit Care Med. 2003;31(2):584–90.

    Article  CAS  PubMed  Google Scholar 

  24. Von Holst H, Mathiesen T. Electrolyte concentrations in serum and CSF following subarachnoid haemorrhage. Br J Neurosurg. 1990;4:123–6.

    Article  Google Scholar 

  25. Harrington MG, Salomon RM, Pogoda JM, et al. Cerebrospinal fluid sodium rhythms. Cerebrospinal Fluid Res. 2010;7:3–11.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Gagliardi RJ. Prognostic value of potassium and sodium levels in cerebrospinal fluid and blood in patients with coma. Study of 55 cases. Arq Neuropsiquiatr. 1982;40:230–8.

    Article  CAS  PubMed  Google Scholar 

  27. Baldy-Moulinier M. Cerebral blood flow and membrane ionic pump. Eur Neurol. 1972;6:107–13.

    Article  CAS  Google Scholar 

  28. Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012;4(147):147ra111.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Tanno H, Nockels RP, Pitts LH, Noble LJ. Breakdown of the blood–brain barrier after fluid percussive brain injury in the rat. Part 1: distribution and time course of protein extravasation. J Neurotrauma. 1992;9(1):21–32.

    Article  CAS  PubMed  Google Scholar 

  30. Tanno H, Nockels RP, Pitts LH, Noble LJ. Breakdown of the blood–brain barrier after fluid percussion brain injury in the rat: Part 2: effect of hypoxia on permeability to plasma proteins. J Neurotrauma. 1992;9(4):335–47.

    Article  CAS  PubMed  Google Scholar 

  31. Jiang JY, Lyeth BG, Kapasi MZ, Jenkins LW, Povlishock JT. Moderate hypothermia reduces blood–brain barrier disruption following traumatic brain injury in the rat. Acta Neuropathol. 1992;84:495–500.

    Article  CAS  PubMed  Google Scholar 

  32. Fukuda K, Tanno H, Okimura Y, Nakamura M, Yamaura A. The blood–brain barrier disruption to circulating proteins in the early period after fluid percussion brain injury in rats. J Neurotrauma. 1995;12(3):315–24.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

JRB was supported by a Practitioner Fellowship from the Royal Perth Hospital Medical Research Foundation.

Conflict of interest

Melanie M. Saw, Jenny Chamberlain, Michelle Barr, Matt P.G. Morgan, John R. Burnett, and Kwok M. Ho declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Melanie M. Saw.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saw, M.M., Chamberlain, J., Barr, M. et al. Differential Disruption of Blood–Brain Barrier in Severe Traumatic Brain Injury. Neurocrit Care 20, 209–216 (2014). https://doi.org/10.1007/s12028-013-9933-z

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1007/s12028-013-9933-z

Keywords